Costs and End-of-Life Care in the NICU: Lessons for the MICU?
Costs and End-of-Life Care in the NICU: Lessons for the MICU?
复制标题
DOI：
10.1111/j.1748-720x.2011.00588.x
复制
发表时间：
2011-06-01
影响因子：
2.1
通讯作者：
Meadow, William L.
中科院分区：
文献类型：
--
作者：
Lantos, John D.;Meadow, William L.
新生儿重症监护病房 (NICU) 和医疗重症监护病房 (MICU) 都非常昂贵。 NICU 的成本效益以及 NICU 患者亚群的长期结果已得到广泛评估。新生儿重症监护室 (NICU) 治疗是最具成本效益的高科技干预措施之一。大多数患者情况良好。 MICU 的成本效益评估较少，几乎没有长期结局研究。仔细审查昂贵的高科技干预措施的政策制定者最好研究一下新生儿重症监护室中发现的例子。
Neonatal intensive care units (NICUs) and medical intensive care units (MICUs) are both very expensive. The cost-effectiveness of NICUs has been extensively evaluated, as has the long-term outcomes of subpopulations of NICU patients. NICU treatment is among the most cost-effective of high-tech interventions. And most patients do well. There are fewer evaluations of cost-effectiveness in the MICU and almost no long-term outcome studies. Policymakers who scrutinize expensive high-tech interventions would do well to study the examples found in the NICU.